Collection 會議論文/會議摘要 [6/9] 期刊論文 [39/39] Siblings 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Community Statistics 近3年內發表的文件:21(43.75%) 含全文筆數:45(93.75%) 文件下載次數統計 下載大於0次:45(100.00%) 下載大於100次:37(82.22%) 檔案下載總次數:11445(0.21%) 最後更新時間: 2024-12-01 03:15 Top Upload Loading... Top Download Loading... Recent Submissions DKK1 as a chemoresistant protein mo... Comprehensive genomic profiling and... Predictive value of FCGBP expressio... Epstein-barr virus BRLF1 induces PD... Germline mutations of homologous re... The prognostic role of LAG-3 expres... Topical antibiotic prophylaxis for ... Phase 1 studies of D07001-F4 and D0... The emergence of RAS mutations in p... Dual role of sprouty2 as an inhibit...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-48 of 48. (1 Page(s) Totally) 1  View [10|25|50] records per page

Date	Title	Relation
2024-09-27	DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer	Oncogenesis. 2024 Sep 27;13:Article number 34.
2024-06-19	Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer	Cancer Medicine. 2024 Jun 19;13(12).
2024-05-03	Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapy	Aging. 2024 May 03;16(9):7889-7901.
2024-03-15	Epstein-barr virus BRLF1 induces PD-L1 expression in nasopharyngeal carcinoma cells	Viral Immunology. 2024 Mar 15;37(2):115-123.
2024-02-13	Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan	Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
2024-02	Topical antibiotic prophylaxis for preventing surgical site onfections of clean wounds: A systematic review and meta-analysis	Surgical Infections. 2024 Feb;25(1):32-38.
2023-11	The prognostic role of LAG-3 expression in metastatic colorectal cancer	Annals of Oncology. 2023 Nov;34(Suppl. 4):S1514-S1515.
2023-10	The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: A noninterventional, uncontrolled multicenter study	British Journal of Cancer. 2023 Oct;129(6):947-955.
2023-07	Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer	Molecular Carcinogenesis. 2023 Jul;62(7):951-962.
2023-06	Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors	Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148.
2023-03	HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study	European Journal of Cancer. 2023 Mar;181:62-69.
2023-02-03	MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition	Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
2023-01-30	Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma	Cancers. 2023 Jan 30;15(3):Article number 854.
2022-11	CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer	British Journal of Cancer. 2022 Nov;127(9):1615-1628.
2022-11	BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma	Annals of Oncology. 2022 Nov;33(Suppl. 9):S1472-S1473.
2022-10-31	PD-L1 expression in high-risk early-stage colorectal cancer-its clinical and biological significance in immune microenvironment	International Journal of Molecular Sciences. 2022 Oct 31;23(21):Article number 13277.
2022-10-23	Real-world comparative effectiveness of nivolumab versus pembrolizumab in patients with unresectable hepatocellular carcinoma	Pharmaceutics. 2022 Oct 23;14(11):Article number 2263.
2022-07-13	SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma	Journal of Experimental and Clinical Cancer Research. 2022 Jul 13;41:Article number 220.
2022-06	Role of high ubiquitin-conjugating enzyme E2 expression as a prognostic factor in nasopharyngeal carcinoma	Oncology Letters. 2022 Jun;23(6):Article number 194.
2022-02-01	A prediction model for tumor recurrence in stage II–III colorectal cancer patients: From a machine learning model to genomic profiling	Biomedicines. 2022 Feb 1;10(2):Article number 340.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-12-08	Association between altered oncogenic signaling pathways and overall survival of patients with metastatic colorectal cancer	Diagnostics. 2021 Dec 8;11(12):Article number 2308.
2021-10-19	SOD2 enhancement by long-term inhibition of the pi3k pathway confers multi-drug resistance and enhanced tumor-initiating features in head and neck cancer	International Journal of Molecular Sciences. 2021 Oct 19;22(20):Article number 11260.
2021-07-05	Age as a modifier of the effects of chemoradiotherapy with infusional 5-fluorouracil after D2 dissection in gastric cancer	Aging. 2021 Jul 5;13(13):17337-17348.
2021-06-12	Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers	Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
2021-05	A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2021-02-24	New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis	International Journal of Molecular Sciences. 2021 Feb 24;22(5):Article number 2252.
2021-01-04	O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinoma	Journal of Biomedical Science. 2021 Jan 4;28:Article number 2.
2020-07-02	BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells	Autophagy. 2020 Jul 2;16(7):1296-1313.
2020-05	Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy	Pathology Research and Practice. 2020 May;216(5):Article number 152922.
2019-10-19	Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets	Journal of Biomedical Science. 2019 Oct 19;26:Article number 77.
2019-08-24	New insights into mechanisms of cisplatin resistance: From tumor cell to microenvironment	International Journal of Molecular Sciences. 2019 Aug 24;20(17):Article number 4136.
2019-08-20	Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: From next-generation sequencing to clinical significance	Cancer Management and Research. 2019 Aug 20;11:7867-7875.
2019-06	Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol	BMC Cancer. 2019 Jun;19:Article number 640.
2019-06	Comparison of oncologic outcomes in laparoscopic versus open surgery for non-metastatic colorectal cancer: Personal experience in a single institution	Journal of Clinical Medicine. 2019 Jun;8(6):Article number 875.
2018-12	Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells	Biochemical Pharmacology. 2018 Dec;158:327-338.
2018-12	The clinical implication of O6 methylguanine DNA methyltransferase in rectal cancers	Cancer Science. 2018 Dec;109(Suppl. 2):1369.
2018-07-30	High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy	International Journal of Medical Sciences. 2018 Jul 30;15(11):1171-1178.
2018-05	A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers	Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556.
2018-01	O6BG modulates the repair activity of homologous recombination and its clinical application	Cancer Science. 2018 Jan;109(Suppl. 1):379.
2017-12-13	HDAC2 and HDAC5 up-regulations modulate survivin and miR-125a-5p expressions and promote hormone therapy resistance in estrogen receptor positive breast cancer cells	Frontiers in Pharmacology. 2017 Dec 13;8(DEC):Article number 902.
2017-09	Inhibition of the ubiquitin-conjugating enzyme E2B restores the BCNU sensitivity of cancer cells by regulating MGMT ubiquitination	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 55P.
2015-09	O6-Methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma	International Journal of Cancer. 2015 Sep;137(6):1291-1305.
2014-12	Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy	Journal of Clinical Pathology. 2014 Dec;67(12):1056-1061.
2014-07	Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: Negative prognostic impact and therapeutic relevance	Tumor Biology. 2014 Jul;35(7):6823-6830.
2013-06-27	Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance	Journal of Biomedical Science. 2013 Jun 27;20(1):Article number 43.
2013-04	SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential	Tumor Biology. 2013 Apr;34(2):1107-1117.
2012-08	Rsf-1 expression in rectal cancer: With special emphasis on the independent prognostic value after neoadjuvant chemoradiation	Journal of Clinical Pathology. 2012 Aug;65(8):687-692.

Showing items 1-48 of 48. (1 Page(s) Totally) 1  View [10|25|50] records per page